VRAX Financial Model

Quarterly and annual income statement, cash flow and balance sheet line items for Virax Biolabs Group Limited Ordinary Shares: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Jun 30, 2026.

VRAX – Virax Biolabs Group Limited Ordinary Shares stock overview